Lannett Starts Trial For Lantus Rival With HEC

Clinical trial
A Clinical Trial For Lannett And HEC’s Insulin Glargine Has Been Initiated • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Biosimilars

More from Products